Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium-induced colitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 9, 2006, Pages 1372-1380

  Murthy, Ashlesh K ^a   Dubose, Candice N ^a   Banas, Jeffrey A ^c   Coalson, Jacqueline J ^b   Arulanandam, Bernard P ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c Center for Immunology and Microbial Disease   (United States)

Author keywords

DSS; IgA; Inflammation; pIgR

Indexed keywords

DEXTRAN SULFATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; SECRETORY COMPONENT; SECRETORY IMMUNOGLOBULIN;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELIAC DISEASE; CELL INFILTRATION; COLITIS; COLON MUCOSA; COLON ULCER; COMMENSALISM; CONTROLLED STUDY; CRYPT CELL; ENTERITIS; EPITHELIUM CELL; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; INTESTINE FLORA; INTESTINE SECRETION; MACROPHAGE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 33746594069     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04312.x     Document Type: Article

References (56)

1. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292: 1115-18.
2. Lamm ME. Interaction of antigens and antibodies at mucosal surfaces. Annu. Rev. Microbiol. 1997; 51: 311-40.
3. Farrell RJ, LaMont JT. Microbial factors in inflammatory bowel disease. Gastroenterol. Clin. North Am. 2002; 31: 41-62.
4. Podolsky DK. Inflammatory bowel disease. N. Engl. J. Med. 2002; 347: 417-29.
5. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000; 288: 2222-6.
6. Lamm ME, Robinson JK, Kaetzel. CS. Transport of IgA immune complexes across epithelial membranes: new concepts in mucosal immunity. Adv. Exp. Med. Biol. 1992; 327: 91-4.
7. Kaetzel CS, Robinson JK, Chintalacharuvu KR, Vaerman JP, Lamm ME. The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc. Natl Acad. Sci. USA 1991; 88: 8796-800.
8. Mestecky J, McGhee JR. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 1987; 40: 153-245.
9. Mestecky J, Russell MW, Elson CO. Intestinal IgA: novel views on its function in the defense of the largest mucosal surface. Gut 1999; 44: 2-5.
10. Corthesy B, Kraehenbuhl JP. Antibody-mediated protection of mucosal surfaces. Curr. Top. Microbiol. Immunol. 1999; 236: 93-111.
11. Brandtzaeg P. The human intestinal immune system: basic cellular and humoral mechanisms. Baillieres Clin. Rheumatol. 1996; 10: 1-24.
12. Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, Phalipon A. Anti-inflammatory role for intracellular dimeric immunoglobulin A by neutralization of lipopolysaccharide in epithelial cells. Immunity 2003; 18: 739-49.
13. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl Acad. Sci. USA 1992; 89: 6901-5.
14. Hocini H, Bomsel M. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J. Infect. Dis. 1999; 179 (Suppl. 3): S448-53.
15. Mostov KE. Transepithelial transport of immunoglobulins. Annu. Rev. Immunol. 1994; 12: 63-84.
16. Kaetzel CS. Polymeric Ig receptor: defender of the fort or Trojan horse? Curr. Biol. 2001; 11: R35-8.
17. Nikolova EB, Tomana M, Russell MW. All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone. Scand. J. Immunol. 1994; 39: 275-80.
18. Russell MW, Reinholdt J, Kilian M. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation. Eur. J. Immunol. 1989; 19: 2243-9.
19. Honorio-Franca AC, Launay P, Carneiro-Sampaio MM, Monteiro RC. Colostral neutrophils express Fc alpha receptors (CD89) lacking gamma chain association and mediate noninflammatory properties of secretory IgA. J. Leukoc. Biol. 2001; 69: 289-96.
20. Wolf HM, Fischer MB, Puhringer H, Samstag A, Vogel E, Eibl MM. Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. Blood 1994; 83: 1278-88.
21. Wolf HM, Hauber I, Gulle H. et al. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 inhuman monocytes. Clin. Exp. Immunol. 1996; 105: 537-43.
22. Wolf HM, Vogel E, Fischer MB, Rengs H, Schwarz HP, Eibl MM. Inhibition of receptor-dependent and receptor-independent generation of the respiratory burst in human neutrophils and monocytes by human serum IgA. Pediatr. Res. 1994; 36: 235-43.
23. Cataldo F, Marino V, Ventura A, Bottaro G, Corazza GR. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and 'Club del Tenue' Working Groups on Coeliac Disease. Gut 1998; 42: 362-5.
24. Meini A, Pillan NM, Villanacci V, Monafo V, Ugazio AG, Plebani A. Prevalence and diagnosis of celiac disease in IgA-deficient children. Ann. Allergy Asthma Immunol. 1996; 77: 333-6.
25. Collin P, Maki M, Keyrilainen O, Hallstrom O, Reunala T, Pasternack A. Selective IgA deficiency and coeliac disease. Scand. J. Gastroenterol. 1992; 27: 367-71.
26. MacDermott RP, Stenson WF. Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv. Immunol. 1988; 42: 285-328.
27. MacPherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996; 38: 365-75.
28. Brandtzaeg P, Nilssen DE. Mucosal aspects of primary B-cell deficiency and gastrointestinal infections. Curr. Opin. Gastroenterol. 2000; 11: 532-40.
29. Hanson LA, Bjorkander J, Carlsson B, Roberton D, Soderstrom T. The heterogeneity of IgA deficiency. J. Clin. Immunol. 1988; 8: 159-62.
30. Friman V, Nowrouzian F, Adlerberth I, Wold AE. Increased frequency of intestinal Escherichia coli carrying genes for S fimbriae and haemolysin in IgA-deficient individuals. Microb. Pathog. 2002; 32: 35-42.
31. Van der Waaij LA, Limburg PC, Mesander G, Van der Waaij D. In vivo IgA coating of anaerobic bacteria in human feces. Gut 1996; 38: 348-54.
32. Harriman GR, Bogue M, Rogers P. et al. Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J. Immunol. 1999; 162: 2521-9.
33. Johansen FE, Pekna M, Norderhaug IN. et al. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J. Exp. Med. 1999; 190: 915-22.
34. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344-67.
35. Araki A, Kanai T, Ishikura T et al. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 2005; 40: 16-23.
36. Aubert JD, Pare PD, Hogg JC, Hayashi. S. Platelet-derived growth factor in bronchiolitis obliterans-organizing pneumonia. Am. J. Respir. Crit. Care Med. 1997; 155: 676-81.
37. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993; 69: 238-49.
38. Axelsson LG, Landstrom E, Goldschmidt TJ, Gronberg A, Bylund-Fellenius AC. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4 (+)-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm. Res. 1996; 45: 181-91.
39. Russell MW, Sibley DA, Nikolova EB, Tomana M, Mestecky. J. IgA antibody as a non-inflammatory regulator of immunity. Biochem. Soc. Trans. 1997; 25: 466-70.
40. Uren TK, Johansen FE, Wijburg OL, Koentgen F, Brandtzaeg P, Strugnell RA. Role of the polymeric Ig receptor in mucosal B cell homeostasis. J. Immunol. 2003; 170: 2531-9.
41. Shimada S, Kawaguchi-Miyashita M, Kushiro A et al. Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA. J. Immunol. 1999; 163: 5367-73.
42. Lindh E. Increased risistance of immunoglobulin A dimers to proteolytic degradation after binding of secretory component. J. Immunol. 1975; 114: 284-6.
43. Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthesy B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 2002; 17: 107-15.
44. Eckmann L. Innate immunity and mucosal bacterial interactions in the intestine. Curr. Opin. Gastroenterol. 2004; 20: 82-8.
45. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-41.
46. Schneeman TA, Bruno MEC, Schjerven H, Johansen FE, Chady L, Kaetzel CS. Regulation of the polymeric Ig receptor by signaling through TLRs 3 and 4. Linking innate and adaptive immune responses. J. Immunol. 2005; 175: 376-84.
47. Mannick EE, Cote RLJR, Schurr JR et al. Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor-1 knock-out mice. J. Gastroenterol. Hepatol. 2005; 20: 371-80.
48. Arulanandam BP, Raeder RH, Nedrud JG, Bucher DJ, Le J, Metzger DW. IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection. J. Immunol. 2001; 166: 226-31.
49. Murthy AK, Sharma J, Coalson JJ, Zhong G, Arulanandam BP. Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice. Cell Immunol. 2004; 230: 56-64.
50. Mostov KE, Kaetzel CS. Immunoglobulin transport and the polymeric immunoglobulin receptor. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock WJ, McGhee JR, eds. Mucosal Immunology. San Diego: Academic Press, 1999; 181-211.
51. Hammerschmidt S, Talay SR, Brandtzaeg P, Chhatwal GS. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 1997; 25: 1113-24.
52. Zhang JR, Mostov KE, Lamm ME. et al. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 2000; 102: 827-37.
53. Fukata M, Michelsen KS, Eri R et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2005; 288: G1055-65.
54. Rachmilewitz D, Katakura K, Karmeli F. et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126: 520-28.
55. Ortega-Cava CF, Ishihara S, Rumi MA. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J. Immunol. 2003; 170: 3977-85.
56. Bruno MEC, West RB, Schneeman TA, Bresnick EH, Kaetzel CS. Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene. Mol. Immunol. 2004; 40: 695-708.